Gabriel Cerrone - Net Worth and Insider Trading
Gabriel Cerrone Net Worth
The estimated net worth of Gabriel Cerrone is at least $44,419 dollars as of 2024-12-16. Gabriel Cerrone is the Director of Cardiff Oncology Inc and owns about 9,525 shares of Cardiff Oncology Inc (CRDF) stock worth over $37,338. Gabriel Cerrone is also the Former Director of Synergy Pharmaceuticals Inc and owns about 1,106,343 shares of Synergy Pharmaceuticals Inc (SGYPQ) stock worth over $7,081. Details can be seen in Gabriel Cerrone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gabriel Cerrone has not made any transactions after 2013-10-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gabriel Cerrone
Gabriel Cerrone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gabriel Cerrone owns 2 companies in total, including Cardiff Oncology Inc (CRDF) , and Hepion Pharmaceuticals Inc (HEPA) .
Click here to see the complete history of Gabriel Cerrone’s form 4 insider trades.
Insider Ownership Summary of Gabriel Cerrone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2012-08-20 | director & 10 percent owner |
| HEPA | Hepion Pharmaceuticals Inc | 2016-08-17 | 10 percent owner |
Gabriel Cerrone Latest Holdings Summary
Gabriel Cerrone currently owns a total of 2 stocks. Among these stocks, Gabriel Cerrone owns 9,525 shares of Cardiff Oncology Inc (CRDF) as of August 20, 2012, with a value of $37,338 and a weighting of 84.06%. Gabriel Cerrone also owns 1,106,343 shares of Synergy Pharmaceuticals Inc (SGYPQ) as of October 29, 2013, with a value of $7,081 and a weighting of 15.94%.
Latest Holdings of Gabriel Cerrone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2012-08-20 | 9,525 | 3.92 | 37,338 |
| SGYPQ | Synergy Pharmaceuticals Inc | 2013-10-29 | 1,106,343 | 0.01 | 7,081 |
Holding Weightings of Gabriel Cerrone
Gabriel Cerrone Form 4 Trading Tracker
According to the SEC Form 4 filings, Gabriel Cerrone has made a total of 0 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years. The most-recent trade in Cardiff Oncology Inc is the acquisition of 108 shares on August 20, 2012, which cost Gabriel Cerrone around $18,330.
According to the SEC Form 4 filings, Gabriel Cerrone has made a total of 0 transactions in Synergy Pharmaceuticals Inc (SGYPQ) over the past 5 years. The most-recent trade in Synergy Pharmaceuticals Inc is the acquisition of 12,000 shares on October 29, 2013, which cost Gabriel Cerrone around $49,080.
Insider Trading History of Gabriel Cerrone
- 1
Gabriel Cerrone Trading Performance
GuruFocus tracks the stock performance after each of Gabriel Cerrone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriel Cerrone is 14.61%. GuruFocus also compares Gabriel Cerrone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriel Cerrone within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gabriel Cerrone's insider trading performs compared to the benchmark.
Performance of Gabriel Cerrone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.44 | | | | | |
| Relative Return to S&P 500(%) | 7.83 | | | | | |
Gabriel Cerrone Ownership Network
Ownership Network List of Gabriel Cerrone
Ownership Network Relation of Gabriel Cerrone
Gabriel Cerrone Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Gabriel Cerrone is the director & 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Gabriel Cerrone made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 414,565 shares made by Gary W Pace ,
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 361,615 shares, with a net purchase of 361,615 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 414,565 shares were bought by its insiders, resulting in a net purchase of 414,565 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
Gabriel Cerrone Mailing Address
Above is the net worth, insider trading, and ownership report for Gabriel Cerrone. You might contact Gabriel Cerrone via mailing address: Via Sant' Andrea 18, Milan L6 20121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
